Impact of timing of immunotherapy and cytoreductive nephrectomy on outcomes in metastatic renal cell carcinoma: Results from the CKCis database.
Changsu Park(McGill University), Ramy Saleh(McGill University Health Centre), Simon Tanguay(McGill University Health Centre), Naveen S. Basappa, Rodney H. Breau(University of Ottawa), Aly‐Khan A. Lalani(Juravinski Cancer Centre), Frédéric Pouliot(Université Laval), Bimal Bhindi, Nazanin Fallah‐Rad(Princess Margaret Cancer Centre), Georg A. Bjarnason(Sunnybrook Health Science Centre), Sunita Ghosh(Tata Memorial Hospital), Lori Wood(Dalhousie University), Vincent Castonguay(Centre hospitalier universitaire de Québec), Christian Kollmannsberger(BC Cancer Agency), Antonio Finelli(University Health Network), Feras A. Moria(McGill University Health Centre), Dominick Bossé(Dana-Farber Cancer Institute), Daniel Yick Chin Heng(University of Calgary), Jeffrey Graham(University of Calgary)
Cited by 0
Related Papers
European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I
|European Urology|2008|617
Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
|Cancer Discovery|2018|520
Exosomes Induce Fibroblast Differentiation into Cancer-Associated Fibroblasts through TGFβ Signaling
|Molecular Cancer Research|2018|322
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I
|The Journal of Urology|2020|268
Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma
|Journal for ImmunoTherapy of Cancer|2018|267